SELLAS Life Sciences (SLS) Other Operating Expenses (2010 - 2023)
SELLAS Life Sciences' (SLS) quarterly Other Operating Expenses came in at $184000.0 in Q1 2023, up 2144.44% year-on-year from $8198.0 in Q1 2022, and up 48.39% on a QoQ basis from $124000.0 in Q3 2022.
SELLAS Life Sciences (SLS) Other Operating Expenses (2010 - 2023) Analysis & Trends
SELLAS Life Sciences (SLS) has 14 years of Other Operating Expenses data on file, last reported at $184000.0 in Q1 2023.
- On a quarterly basis, Other Operating Expenses rose 2144.44% year-over-year to $184000.0 in Q1 2023; TTM through Dec 2023 was $184000.0, a 43.21% decrease from a year earlier, with the FY2022 full-year figure at $10.1 million, up 71.19% from the prior year.
- Other Operating Expenses for Q1 2023 stood at $184000.0, up from $124000.0 in the prior quarter.
- Over the last five years, Other Operating Expenses for SLS reached as high as $5.7 million in Q4 2021 and fell as low as -$178000.0 in Q1 2019.
- Historically, Other Operating Expenses has averaged $415466.7 across 5 years, with a median of -$18000.0 in 2019.
- Across the five-year window, Other Operating Expenses slumped 668.42% in 2021 and surged 2144.44% in 2023, its largest moves.
- Year by year, Other Operating Expenses stood at -$21000.0 in 2019, then jumped by 190.48% to $19000.0 in 2020, then surged by 29900.0% to $5.7 million in 2021, then slumped by 97.82% to $124000.0 in 2022, then soared by 48.39% to $184000.0 in 2023.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $184000.0 in Q1 2023, $124000.0 in Q3 2022, and $209000.0 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | SELLAS Life Sciences | 1.96 Bn | 1.96 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 184,000.00 |
| Sep 30, 2022 | 124,000.00 |
| Jun 30, 2022 | 209,000.00 |
| Mar 31, 2022 | -9,000.00 |
| Dec 31, 2021 | 5.70 Mn |
| Sep 30, 2021 | -108,000.00 |
| Jun 30, 2021 | -160,000.00 |
| Mar 31, 2021 | -158,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Jun 30, 2020 | -158,000.00 |
| Mar 31, 2020 | -79,000.00 |
| Dec 31, 2019 | -21,000.00 |
| Sep 30, 2019 | -18,000.00 |
| Jun 30, 2019 | 885,000.00 |
| Mar 31, 2019 | -178,000.00 |
| Dec 31, 2018 | 979,000.00 |
| Sep 30, 2018 | 2.77 Mn |
| Jun 30, 2018 | 602,000.00 |
| Mar 31, 2018 | -2.31 Mn |
| Dec 31, 2017 | -102,000.00 |